Reaching Target Hemoglobin Level and Having a Functioning Arteriovenous Fistula Significantly Improve One Year Survival in Twice Weekly Hemodialysis by Elamin, S & Abu-Aisha, H
81
Arab Journal of Nephrology and Transplantation
Arab Journal of Nephrology and Transplantation. 2012 May;5(2):81-6
Original Article AJNT
Abstract
 Introduction: This is a prospective study of a cohort of 
1011 patients maintained on regular hemodialysis (HD) 
in Khartoum, Sudan, studied in the year 2009 and re-
evaluated one year later. Their survival rates in November 
2010 were related to their baseline characteristics. 
Methods: Demographic and clinical data of studied 
patients was collected by direct patient interviews and 
dialysis records revision. Survival rates were calculated 
using the Kaplan Meier method.
Results: Patients had a median age of 45 years and a 
median duration on dialysis of 25 months. Two thirds 
of patients were males and 4.2% were children. Studied 
patients had a one-year survival rate of 86%. Most 
patients (74.8%) received twice weekly HD, and their 
survival rate was lower than patients receiving thrice 
weekly HD (85% versus 89%, P = 0.06). The strongest 
independent predictors of mortality were lack of a 
documented measure of dialysis adequacy (HR = 2.7, P = 
0.00), poor functional capacity (HR = 2.4, P = 0.00), lack 
of a functioning AV fistula (HR = 2.0, P = 0.00), age ≥ 
65 years (HR = 1.6, P = 0.02) and cardiovascular disease 
(HR = 1.5, P = 0.04). Patients with hemoglobin level 
< 10 g/dl had significantly lower survival rates (81% 
versus 92%, P = 0.00) compared to other patients. HD 
patients’ perception of their own general health was also 
significantly correlated to their survival rates (P = 0.00). 
Conclusion: Patients on thrice weekly HD did marginally 
better than those on twice weekly HD. In the latter group, 
however, having an AV fistula and a hemoglobin level 
of > 10 g/dl appeared to have a positive effect on their 
survival. Twice weekly HD could be acceptable for many 
patients provided other aspects of renal care are cared for 
adequately.
Keywords: Hemodialysis; Sudan; Survival
The authors declared no conflict of interest.
 Introduction
In June 2009, we conducted a national survey for end 
stage renal disease (ESRD) patents maintained on renal 
replacement therapy (RRT) in Sudan [1]. At that time, 
there were 41 working hemodialysis (HD) centers in the 
country serving a total of 2858 patients. The majority 
of these patients were being dialyzed in Khartoum; 
where there were 12 governmental HD centers serving 
1003 patients and 16 private HD centers serving 1069 
patients. 
During the ensuing months, restructuring of HD services 
in Khartoum resulted in the closure of 15 private HD 
centers and the creation of additional governmental 
centers. In November 2010, we conducted another survey 
of the thirteen HD centers from the original cohort that 
continued to provide HD services in Khartoum. A total 
of 1011 patients were being dialyzed in these 13 centers 
in June 2009. This included 968 adult and 43 pediatric 
ESRD patients who had been established on HD for three 
months at least. One of the aims of this second survey 
was to evaluate the survival of this cohort of patients and 
relate it to their base-line characteristics.
Methods
Data of prevalent HD patients was collected by direct 
patient interviews and included demographic data, 
the most probable cause of ESRD, diabetic status, 
duration on HD, number of HD sessions, vascular 
access, urine volume and personal history of ischemic 
heart disease, cerbrovascular disease or peripheral 
vascular disease. Ischemic heart disease was defined 
by history of angina, myocardial infarction or coronary 
intervention. Cerebrovascular disease was defined by 
history of stroke or transient ischemic attacks. Peripheral 
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The one-year survival rate of patients undergoing thrice 
weekly HD was 89% compared to 85% for patients 
undergoing twice weekly HD (P = 0.06). More chidren 
were offered thrice weekly HD compared to adults 
(63% versus 23%, P = 0.00). There was no difference 
in age or gender between adult patients receiving thrice 
or twice weekly HD. Adult patients receiving thrice 
weekly HD were more likely to be anuric (76.5% versus 
41.7%, P=0.00) and to have CVD (17.3% versus 11.1%, 
P=0.01) compared to patients receiving twice weekly 
HD. They were also more likely to achieve pre-HD 
BP targets (61.5% versus 54.5%, P=0.047), to achieve 
post-HD BP targets (42.8% versus 31.5%, P=0.00), to 
have a hemoglobin level ≥ 10 g/dl (59.1% versus 46.5%, 
P=0.01) and to have a documented measure of dialysis 
adequacy (42.7% versus 10.7%, P=0.00).
The strongest independent predictors of poor survival 
among patients undergoing twice weekly HD were poor 
functional capacity (HR = 2.6; P = 0.00), lack of dialysis 
adequacy monitoring (HR = 2.5, P = 0.01), lack of a 
functioning AV fistula (HR = 2.0, P = 0.00), age ≥ 65 
years (HR = 1.9, P = 0.001) and male gender (HR = 1.6, 
P = 0.01).  
The strongest independent predictors of poor survival 
among patients undergoing thrice weekly HD were lack 
of dialysis adequacy monitoring (HR = 3.1, P = 0.01), 
lack of a functioning AV fistula (HR = 2.8, P = 0.01), 
poor functional capacity (HR = 2.8, P = 0.02) and CVD 
(HR = 2.5, P = 0.03). There was no significant difference 
in survival probability between males and females in this 
group of patients.
Data related to hemoglobin level, urine output and blood 
pressure readings were missing for 47%, 16% and 16% of 
patients respectively, hence these three variables were not 
included in the cox regression model. However, patients 
with hemoglobin level < 10 g/dl had a significantly higher 
mortality hazard compared to patients with hemoglobin 
level ≥10 g/dl (HR = 2.1, CI 1.4-3.1, P = 0.00). Patients 
with a baseline pre-HD BP ≥ 140/90 mmHg also had 
a significantly higher mortality hazard compared to 
patients with pre-HD BP < 140/90 mmHg (HR = 1.4, CI 
1.0-1.9, P = 0.02).
During the original survey, prevalent HD patients were 
asked to rate their evaluation of their own health on a 
Likert-type scale. Patients who thought their general health 
was “excellent”, “very good”, “good”, “acceptable” and 
“poor” constituted 3.8%, 15.6%, 48.7%, 25.9% and 6% 
of the study population respectively. This evaluation was 
closely reflected on those patients’ survival probabilities 
(Figure-1).
Discussion
The cohort of patients of this study represents 37% of 
patients who were maintained on regular dialysis in Sudan 
in 2009. Their baseline characteristics closely reflect the 
characteristics of the Sudanese dialysis population as 
described in a previous report [1]. We believe that the 
findings of this study provide reasonable estimates of the 
outcomes of dialysis services at the national level.
The one-year survival rate for prevalent adult dialysis 
patients in this study (86%) is similar to the reported 
survival rate of prevalent adult dialysis patients in UK in 
2009 (86.2%) [2]. However, it must be noted that dialysis 
patients in UK have a higher median age and a heavier 
comorbidity burden than the current study population. 
On the other hand, life expectancy at birth among UK 
general population is 78 years for males and 82 years 
for females compared to 59 years for males and females 
vascular disease was defined by history of intermittent 
claudication, amputation due to ischemia or peripheral 
revascularization. Patients were asked whether they 
needed assistance from family members in activities 
of daily living, and considered to have poor functional 
capacity if such assistance was required. Patients were 
also asked to rate their evaluation of their own general 
health on a Likert-type scale composed of five items; 
excellent, very good, good, acceptable and poor. Data 
related to hemoglobin level and measurements of dialysis 
adequacy within the previous month was collected form 
patients’ medical records. The pre-HD and post-HD 
blood pressure (BP) measurements of the previous three 
HD sessions were recorded and their average taken. 
Analysis was done using SPSS for windows version 19 
(SPSS Inc. Chicago, IL, USA).Unadjusted survival rates 
were estimated using Kaplan-Meier survival analysis and 
compared using the log rank test. Patients were censored 
at the time of transplantation, transfer to another dialysis 
modality or referral to another HD center. Cox regression 
analysis was used to estimate the hazard ratio of potential 
risk factors. Variables with more than 5% missing data 
were not included in cox regression analysis. Proportions 
were compared using Chi-square test. P values less than 
0.05 were considered statistically significant. 
Results
The median age of prevalent HD patients in this study was 
45 years (range: 6-95 years). Fifteen percent of patients 
were aged ≥ 65 years and 4.2% were children aged ≤ 18 
years.  Two thirds of patients were males. The median 
duration on dialysis was 25 months, 22% of patients had 
been maintained on HD for ≥ 5 years and 3% had been 
maintained on HD for ≥ 10 years. 
The most probable cause of renal failure was undetermined 
in 41% of patients, hypertension (25%), diabetes mellitus 
(10%), obstructive uropathy (11%), glomerulonephritis 
(4%), polycystic kidney disease (3%), and pyelonephritis 
(3%).
Diabetic patients constituted 12% of the study population. 
Cardiovascular disease (CVD) was reported by 12.2% of 
patients at baseline, including 7% patients with history of 
ischemic heart disease, 4% with history of cerebrovascular 
disease and 3.7% with history of peripheral vascular 
disease. Half the patients were anuric. Fifteen percent 
of patients had poor functional capacity and required 
assistance from family members in activities of daily 
living. 
The majority of patients (74.8%) received two sessions of 
HD per week and most patients (82.6%) had a functioning 
arteriovenous fistula (AVF) at baseline. Both the target 
pre-dialysis blood pressure (BP) of < 140/90 mmHg 
and the target post-dialysis BP of < 130/80 mmHg were 
achieved by 30.2% of patients. Fifty percent of patients 
had hemoglobin level ≥ 10 g/dl. Eighteen percent of 
patients had a documented measure of dialysis adequacy 
(urea reduction ratio).
Table-1 outlines the status of this cohort of prevalent HD 
patients after one year of follow-up. During the original 
survey, 226 patients from the study cohort (23%) stated 
that they were being prepared for live-related kidney 
transplantation. Of those, only 38 patients (16.8%) 
received a kidney transplant during the following year.
The one-year survival rate in this group of prevalent 
HD patients was 86%. In Cox regression analysis, the 
strongest independent predictors of poor survival were 
lack of a documented measure of dialysis adequacy, poor 
functional capacity, lack of a functioning AV fistula, age 
≥ 65 years and CVD (Table-2). 
Table 1: Status of the study cohort of prevalent HD patients after one year follow-up (N = 1011)
Status Number Proportion
Regular dialysis at the same HD center 676 66.9
Referred to another HD center 81 8
Dead 152 15
Received a kidney transplant 47 4.6
Transferred to peritoneal dialysis 10 1.0
Regained dialysis independence 1 0.1
Lost to follow up 44 4.4
Total 1011 100
Table 2: The mortality hazards associated with various baseline characteristics of the study cohort of prevalent HD patients
Baseline characteristics HR 95% CI P value
Age ≥ 65 years 1.6 1.1-2.2 0.02*
Male gender 1.3 1.0-1.8 0.1
Duration on dialysis (months) 1.0 0.9-1.01 0.7
Diabetes mellitus 1.2 0.8-1.9 0.3
Cardiovascular disease 1.5 1.0-2.3 0.04*
Poor functional capacity 2.4 1.7-3.5 0.00*
Lack of a functioning AV fistula 2.0 1.4-2.9 0.00*
No documented measure of dialysis adequacy 2.7 1.6-4.7 0.00*
Twice versus thrice weekly HD 0.9 0.7-1.5 0.9
HR: hazards ratio; CI: confidence interval
 * Statistically significant
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in Sudan [3]. Such differences in patient and population 
characteristics make direct comparison of survival rates 
inappropriate.
In Sudan, most patients are offered twice weekly HD 
for economic reasons. Earlier K-DOQI guidelines set 
thrice weekly sessions as the minimum frequency level 
of adequate HD. This standpoint changed in response 
to an important cross-sectional study from the USA that 
reported lower mortality risk (RR = 0.76, P = 0.02) for 
twice weekly HD compared to thrice weekly HD among 
prevalent patients. The authors attributed this survival 
advantage to patient selection and greater residual kidney 
function (RKF) among patients maintained on twice 
weekly HD [5]. The most recent K-DOQI guidelines 
recommend two to six HD sessions per week, provided 
that the HD schedule is tailored to achieve a minimum 
standard Kt/V of 2.0 per week [4]. In the absence of RKF, 
it is not possible to reach this target using a twice-weekly 
schedule. Thus, twice-weeklydialysis is only permissible 
in a few patients with RKF greater than 2 ml/min/1.73m2 
who have stable function and do not have excessive fluid 
gains [4].
Intermittent dialysis has reduced efficiency when 
compared to continuous dialysis; efficiency defined as 
the effect of lowering solute concentration achieved for a 
given level of dialysis dose. Intermittent dialysis is also 
less likely to achieve adequate volume control in anuric 
patients. In a representative sample of the US dialysis 
population undergoing thrice weekly HD, mortality and 
cardiovascular event rates were significantly higher on the 
day after the long (2-day) interdialytic interval compared 
to other days [6]. Patients undergoing twice weekly 
HD are required to tolerate an even longer interdialytic 
interval of three days. The higher mortality observed in 
patients undergoing twice weekly HD in this study is not 
unexpected, bearing in mind that 42% of them had no 
significant RKF.
The quality of delivered HD is of no less importance 
than the number of weekly HD sessions. In this study, 
lack of a documented measure of dialysis adequacy 
was consistently associated with increased mortality, 
even among patients receiving three sessions of HD per 
week. Lower survival rates achieved by males compared 
to females on twice weekly HD are likely to be due to 
under-dialysis. Males generally have a larger muscle 
bulk and are less likely to achieve adequate dialysis on a 
twice weekly regimen.
More than 80% of HD patients in this study were dialyzed 
through an arteriovenous fistula (AVF), in accordance 
with published guidelines. Dialysis via a central venous 
catheter (CVC) doubled the one-year mortality hazard 
compared to a functioning AVF. Moreover, there was 
no difference in mortality hazard between cuffed and 
non-cuffed HD catheters. The significantly increased 
mortality of patients undergoing dialysis through a CVC 
is well documented in the literature [7-10]. Data from the 
USRD system reveals that vascular access complications 
account for 16-25% of hospital admissions of HD patients. 
The relative mortality risk was higher for patients with 
CVC compared to AVF (RR = 1.5, P < 0.002). Cause-
specific analysis found higher infection-related deaths 
for CVC compared with AVF in both DM (RR = 2.3, 
P < 0.06) and non-DM patients (RR = 1.8, P < 0.04). 
Deaths due to cardiac causes were also significantly 
higher in CVC than AVF for both DM (RR = 1.5, P < 
0.05) and non-DM patients (RR = 1.3, P < 0.05) [8]. In an 
analysis of the UK Renal Registry, the mean percentage 
of prevalent HD patients using definitive access (AVF 
or AVG) in a center was 69.8% in 2005. There was a 
small but significant positive association between the 
percentage of HD patients using an AVF or AVG in a 
center and one-year uncensored survival. The type of 
access in use was able to explain 6% of the variation in 
center level survival [9]. In fact; a recent study attributed 
the survival advantage of PD compared to HD in the first 
1-2 years to the higher rates of CVC use at the initiation 
of HD. After analyzing data of 40,526 incident dialysis 
patients from the Canadian Organ Replacement Register, 
the authors found that the one-year mortality of HD-AVF/
AVG patients was similar to PD patients while HD-CVC 
patients had an 80% higher mortality [10]. 
HD patients perceptions of their own health in this 
study were closely reflected on their survival rates. 
Illness perceptions have been shown to be important 
determinants of functional and psychosocial outcomes, 
including quality of life and treatment adherence in 
patients with chronic diseases. In a small prospective 
study in UK, 223 HD patients completed the Revised 
Illness Perception Questionnaire. Treatment control 
perceptions demonstrated a significant association with 
mortality (HR = 0.9, P = 0.03) independently of other 
survival risk factors including comorbidity [11].
In our opinion, the most important aspect of this study 
was demonstrating the impact of vascular access and 
hemoglobin level on patient survival. These two factors 
appear to have a greater effect on patient survival than the 
mere number of weekly HD sessions. It is estimated that a 
non-diabetic patient aged 19-64 years who is maintained 
on twice weekly HD would have a one-year survival 
probability of 97% if he had a functioning AV fistula and 
hemoglobin level ≥10 g/dl at baseline. The same patient 
would have a one-year survival probability of 72% if he 
was being dialyzed through a central venous catheter and 
had hemoglobin level <10 g/dl at baseline. Economic 
barriers prevent the provision of thrice weekly HD for 
the majority of patients in our setting. Nevertheless, we 
believe that improving other aspects of patient care would 
still have a significanst impact on outcomes.
Conclusion
Treatment outcomes of HD services in Sudan are 
acceptable despite the economic limitations. There 
are deficiencies in several aspects of HD patient care, 
including quality assurance of delivered dialysis dose and 
management of anemia. Lack of a documented measure 
of dialysis adequacy and lack of a functioning AV fistula 
were two of the strongest independent predictors of poor 
survival among prevalent HD patients.
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bulk and are less likely to achieve adequate dialysis on a 
twice weekly regimen.
More than 80% of HD patients in this study were dialyzed 
through an arteriovenous fistula (AVF), in accordance 
with published guidelines. Dialysis via a central venous 
catheter (CVC) doubled the one-year mortality hazard 
compared to a functioning AVF. Moreover, there was 
no difference in mortality hazard between cuffed and 
non-cuffed HD catheters. The significantly increased 
mortality of patients undergoing dialysis through a CVC 
is well documented in the literature [7-10]. Data from the 
USRD system reveals that vascular access complications 
account for 16-25% of hospital admissions of HD patients. 
The relative mortality risk was higher for patients with 
CVC compared to AVF (RR = 1.5, P < 0.002). Cause-
specific analysis found higher infection-related deaths 
for CVC compared with AVF in both DM (RR = 2.3, 
P < 0.06) and non-DM patients (RR = 1.8, P < 0.04). 
Deaths due to cardiac causes were also significantly 
higher in CVC than AVF for both DM (RR = 1.5, P < 
0.05) and non-DM patients (RR = 1.3, P < 0.05) [8]. In an 
analysis of the UK Renal Registry, the mean percentage 
of prevalent HD patients using definitive access (AVF 
or AVG) in a center was 69.8% in 2005. There was a 
small but significant positive association between the 
percentage of HD patients using an AVF or AVG in a 
center and one-year uncensored survival. The type of 
access in use was able to explain 6% of the variation in 
center level survival [9]. In fact; a recent study attributed 
the survival advantage of PD compared to HD in the first 
1-2 years to the higher rates of CVC use at the initiation 
of HD. After analyzing data of 40,526 incident dialysis 
patients from the Canadian Organ Replacement Register, 
the authors found that the one-year mortality of HD-AVF/
AVG patients was similar to PD patients while HD-CVC 
patients had an 80% higher mortality [10]. 
HD patients perceptions of their own health in this 
study were closely reflected on their survival rates. 
Illness perceptions have been shown to be important 
determinants of functional and psychosocial outcomes, 
including quality of life and treatment adherence in 
patients with chronic diseases. In a small prospective 
study in UK, 223 HD patients completed the Revised 
Illness Perception Questionnaire. Treatment control 
perceptions demonstrated a significant association with 
mortality (HR = 0.9, P = 0.03) independently of other 
survival risk factors including comorbidity [11].
In our opinion, the most important aspect of this study 
was demonstrating the impact of vascular access and 
hemoglobin level on patient survival. These two factors 
appear to have a greater effect on patient survival than the 
mere number of weekly HD sessions. It is estimated that a 
non-diabetic patient aged 19-64 years who is maintained 
on twice weekly HD would have a one-year survival 
probability of 97% if he had a functioning AV fistula and 
hemoglobin level ≥10 g/dl at baseline. The same patient 
would have a one-year survival probability of 72% if he 
was being dialyzed through a central venous catheter and 
had hemoglobin level <10 g/dl at baseline. Economic 
barriers prevent the provision of thrice weekly HD for 
the majority of patients in our setting. Nevertheless, we 
believe that improving other aspects of patient care would 
still have a significanst impact on outcomes.
Conclusion
Treatment outcomes of HD services in Sudan are 
acceptable despite the economic limitations. There 
are deficiencies in several aspects of HD patient care, 
including quality assurance of delivered dialysis dose and 
management of anemia. Lack of a documented measure 
of dialysis adequacy and lack of a functioning AV fistula 
were two of the strongest independent predictors of poor 
survival among prevalent HD patients.
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